Enjoy complimentary customisation on priority with our Enterprise License!
Overview of the global gene expression market
Technavio's market research study identifies the decreasing cost of DNA sequencing as one of the primary growth factors for the gene expression market. Advancements in science and molecular biology has resulted in the development of the Next-generation sequencing (NGS) market that can analyze multiple fragments in a single run. NGS has resulted in significant cost reduction per genome and per mb which has enabled researchers and pharmaceutical companies analyze multiple fragments at the same time. Additionally, the easy availability of genomes has resulted in increasing number of genomic experiments and research studies. Our market research analysts estimate that this market will grow steadily at a CAGR of almost 11% by 2021.
The integration of genomic data directly into clinical workflows will be one of the key trends that will gain traction to the growth of the gene expression market. Several clinical centers are extensively making use of genomic data to create personalized and targeted treatment by integrating genomic data into clinical workflows. Researchers discover that high-profile examples of the value of analysis of gene expression raises awareness among doctors and patients. Discovery of greater correlation between genetics and disease risk will result in the unification of data and the reduction of data gap. The unified information can be used relevantly to help in treatment as the researchers would be able to make informed decisions faster. The severity of the disease would be limited as the treatment planning for genetic disorders can be started at an early stage.
Competitive landscape and key vendors
The gene expression market is highly competitive due to the presence of several international and regional vendors competing by employing several competitive strategies and increasing investments in R&D. The vendors in the market are increasingly focusing on innovative product launches and M&A to attain a competitive advantage over the other players in the microarray data analysis market. Product innovation and technological advancements aid the vendors to attract end-users as they offer high-quality affordable products.
The leading vendors in the market are -
The other prominent vendors in the market are Fluidigm, GE Healthcare Dharmacon, Illumina, Interpace Diagnostics, Miltenyi Biotec, New England BioLabs, OriGene Technologies, Oxford Nanopore Technologies, PerkinElmer, Phalanx Biotech Group, Promega, QIAGEN, and Zyagen.
Segmentation by product type and analysis of the gene expression market
Gene expression study extensively makes use of several consumables such as chips, reagents, and labelling kits that are integral to confirm that the genes of interest that have been expressed are correct and the extent of which the genes have been expressed matches with the scope of the study. The demand for consumables is also influenced by factors such as high customizability, reusability, and lower price.
Segmentation by application and analysis of the gene expression market
Pharmaceutical and biotechnology companies are increasingly investing in R&D activities for drug development and discovery through gene expression studies and dna microarray analysis. Technological advancements, increasing affordability of genome sequencing technique, and the rising need for new drugs and therapies, will contribute to the growth of the market in the drug discovery segment
Key questions answered in the report include
Technavio also offers customization on reports based on specific client requirement.
Gene expression is a process in which genetic information is utilized for the synthesis of a functional gene product, protein, or RNA. This upcoming research report on the global gene expression market offers insights into the major trends and forthcoming drivers influencing the growth of the healthcare and life sciences industry. Our reports for the industry also follow a scrupulous data collection methodology and offer an analysis of fast growing market segments like lab equipment.
Moreover, to achieve higher accuracy, our industry experts implement an extensive research approach of quantitative and qualitative data collection methodologies and assess the changing demand-supply landscape of the lab equipment sector. The key advantages gained from the adoption of this approach is better statistical models and efficient vendor analysis. By taking into account the market forecast and size and the surging demand for various segments of the lab equipment sector, the market research professionals at Technavio present an all-inclusive picture of the gene expression market from 2017 to 2021.
This forthcoming market research report on the gene expression market also covers vendors like Agilent Technologies, Bio-Rad Laboratories, F. Hoffmann-La Roche, and Thermo Fisher Scientific. According to our industry experts, the exponential rise in the number of cancer cases is expected to impact the global market significantly during the next few years.
The upcoming industry research report on the gene expression market also categorizes the major drivers, growing trends, along with the imminent restraints that the lab equipment sector currently experiences. This upcoming report on the gene expression market also presents insights into the rapidly changing competitive landscape to give clients a complete picture of the forthcoming events within the healthcare and life sciences industry. Technavio also presents in-depth market assessments into the sectors such as oncology and health and wellness.
Our market research methodology for the gene expression market
Technavio also offers clients the possibility to customize every report to suit their specific requirements and offers impressive discounts on all forthcoming reports and future purchases.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by application
PART 07: Market segmentation by product
PART 08: Geographical segmentation
PART 09: Decision framework
PART 10: Drivers and challenges
PART 11: Market trends
PART 12: Vendor landscape
PART 13: Key vendor analysis
PART 14: Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.